HCMSG - Hepatitis C Mentor & Support Group, Inc.

  • Home
  • OUR SERVICES
    • The Circle Model >
      • Circle Model Data Form
    • RESOURCES
    • HepCTraining >
      • Live Training
    • Order Materials
    • Webinars
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us
  • Home
  • OUR SERVICES
    • The Circle Model >
      • Circle Model Data Form
    • RESOURCES
    • HepCTraining >
      • Live Training
    • Order Materials
    • Webinars
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us

NYC councilmember Erik Bottcher offers a lot more than “thoughts & prayers” for the queer community

6/7/2025

0 Comments

 
By Bobby McGuireJune 7, 2025 at 7:00am Queerty

While many in the queer community watch stunned in disbelief as anti-LGBTQ+ rhetoric and legislation designed to dismantle transgender healthcare sweeps across America, a gay councilmember in the heart of queer New York City is refusing to stand still.
Erik Bottcher, representing the historic neighborhoods where Stonewall’s legacy lives on, isn’t just posting rainbow flags or offering sympathetic tweets (the queer equivalent of ‘thoughts and prayers’)—he’s wielding legislative power.
As the current administration actively worked in its first weeks to roll back transgender rights through executive orders, Bottcher and his allies on the city’s LGBTQIA+ Caucus were busy on the counteroffensive, creating a bold legislative package designed to safeguard transgender, gender non-conforming, nonbinary, and intersex (TGNCNBI) New York

TO CONTINUE: https://www.queerty.com/nyc-councilmember-erik-bottcher-offers-a-lot-more-than-thoughts-prayers-for-the-queer-community-20250607/


0 Comments

HealthWatch  As overdose deaths fall, Trump administration proposes cuts to lifesaving Narcan program

6/7/2025

0 Comments

 
​By Kerry BreenEdited By Kierra FrazierMay 8, 2025 / 5:21 PM EDT / CBS News
The Trump administration has proposed cutting a $56 million grant that teaches first responders how to use the lifesaving overdose reversal drug naloxone, which experts say could reverse progress the United States has made in lowering opioid overdose deaths. 
A recent dip in overdose deaths has been credited in part to wider naloxone access. The medication was made available for over-the-counter purchase in 2023 and is standard for first responders to carry. It's even popped up in some classrooms. 
Naloxone, also sold under the brand name Narcan, is available in injectable and nasal spray form. It is an opioid antagonist that attaches to receptors in the brain, reversing and blocking the effects of other opioids, including fentanyl. 
The grant money can be used by state and local organizations for training people on how to use naloxone, as well as administering and distributing the medication. Grantees are expected to establish protocols to refer patients to treatment or support services and provide other safety information about illicit drugs and overdoses. The grant is administered by the Substance Abuse and Mental Health Services Administration. 
"While some skeptics may think that naloxone - and harm reduction more generally - enable people, there is decades of research that show giving people the information and tools they need helps keep people safe," medical anthropologist Jennifer Syvertsen said in an emailed statement. "Naloxone simply enables people to breathe." 

TO CONTINUE READING::
​https://www.cbsnews.com/news/overdose-deaths-narcan-naloxone-harm-reduction-samhsa-trump-cuts/?fbclid=IwY2xjawKm1U1leHRuA2FlbQIxMQBicmlkETFtTmwySjFJR3RmMXAxM21VAR4Ee7kbQFIDYAwwghR4_JtT9M0yW1g29NSxarRYVRlg8qiuR5_c6gxnhl6fLA_aem_J9UJqxAmR7cS1r0vVO1sDg

0 Comments

Disparities in liver cancer risk and outcomes in the LGBTQ community: A literature review.

6/3/2025

0 Comments

 
Meeting Abstract: 2025 ASCO Gastrointestinal Cancers Symposium
Hepatobiliary Cancer  January 27, 2025
​Authors: Fnu Anamika, Akshit Chitkara, Marciano Figueroa, Arshia Adib, and Rushin PatelAuthors Info & Affiliations Publication: Journal of Clinical Oncology  Volume 43, Number 4_suppl
https://doi.org/10.1200/JCO.2025.43.4_suppl.52



Background: Liver cancer continues to be a significant public health concern, particularly among high-risk groups such as individuals with hepatitis infections, alcohol use disorders, and metabolic diseases. While liver cancer disparities have been well-documented among racial and ethnic minority groups, emerging research highlights significant health inequities within the LGBTQ community, including higher rates of risk factors and limited access to screening and care. This literature review aims to assess the extent of liver cancer disparities within the LGBTQ community and identify gaps in prevention, screening, and treatment.

To Continue Reading:   
https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.528
0 Comments

    Archives

    June 2025
    April 2025
    March 2025
    January 2025
    December 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021

    Categories

    All

    RSS Feed

Privacy Policy
Disclaimer:  Information given by Hepatitis C Mentor and Support Group is not a substitute for advice given by your physician or health care provider.  We do not endorse any doctor, hospital, medical group, or treatment.